DUSP2
DUSP2 functions as a negative regulator of MAPK signaling, particularly affecting the ERK1/2 pathway.
DUSP2 mutations have been reported in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T-cell/histiocyte-rich large B-cell lymphoma (T/HRLBCL)[@schuhmacherJUNBDUSP2SGK12019b; @hartmannHighlyRecurrentMutations2016b] and they are relatively frequent in DLBCL.
DUSP2 is one of a number of genes affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus.
These mutations are associated with the ST2 genetic subgroup of DLBCL.
This gene has some recurrent sites of mutations (hot spots).
The mutation pattern in DLBCL implies the preferential accumulation of inactivating mutations.
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
title Publication timing
2012-03-06 : Lohr : DLBCL
2013-08-15 : Morin : DLBCL
2017-10-10 : Reddy : DLBCL
2018-04-12 : Schmitz : DLBCL
| Entity | Tier | Description |
|---|---|---|
 |
1 | high-confidence PMBL/cHL/GZL gene[@dunsCharacterizationDLBCLPMBL2021b] |
 |
1 | aSHM target and high-confidence DLBCL gene [@morinMutationalStructuralAnalysis2013; @lohrDiscoveryPrioritizationSomatic2012a] |
 |
2 | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous |
| Entity | source | frequency (%) |
|---|---|---|
| DLBCL | GAMBL genomes | 10.13 |
| DLBCL | Schmitz cohort | 12.55 |
| DLBCL | Reddy cohort | 9.71 |
| DLBCL | Chapuy cohort | 4.27 |
| FL | GAMBL genomes | 2.31 |
| Entity | aSHM | Significant selection | dN/dS (missense) | dN/dS (nonsense) |
|---|---|---|---|---|
| BL | Yes | No | 1.258 | 17.913 |
| DLBCL | Yes | No | 1.537 | 12.012 |
| FL | Yes | No | 3.206 | 0.000 |
| chr_name | hg19_start | hg19_end | region | regulatory_comment |
|---|---|---|---|---|
| chr2 | 96808901 | 96811913 | intron-1 | enhancer |
| Chromosome | Coordinate (hg19) | ref>alt | HGVSp |
|---|---|---|---|
| chr2 | 96810877 | C>G | D73H |
| chr2 | 96810865 | G>A | R77W |
| chr2 | 96810842 | C>G | E84D |
| chr2 | 96810841 | G>C | L85V |
| chr2 | 96810730 | G>A | P122S |
| chr2 | 96810717 | T>C | Y126C |
| chr2 | 96810706 | C>T | G130R |
| chr2 | 96810597 | C>T | C138Y |
| chr2 | 96810582 | C>T | C143Y |
| chr2 | 96810574 | C>T | A146T |
View coding variants in ProteinPaint hg19 or hg38
View all variants in GenomePaint hg19 or hg38
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.